NanoSurface Biomedical, Inc. is a biotechnology company based in Seattle, WA and founded in 2015. NanoSurface’s technologies specialize in nanopatterned surfaces that imitate the native extracellular matrix and structure cultured cells into physiologically relevant tissue models. Flagship products include NanoSurface Cultureware and the NanoSurface Cytostretcher. NanoSurface Biomedical seeks to accelerate discovery to improve human health by providing innovative products and services for drug development, disease modeling, and cell biology research.